A ratiometric pH sensor based on a tetrahedral framework nucleic acid dual CRISPR system, its preparation method and application

By constructing a ratiometric pH sensor based on a tetrahedral framework nucleic acid dual CRISPR system, the problems of insufficient target specificity and quantitative accuracy in the existing technology have been solved, realizing high-precision pH detection and specific target monitoring, which is suitable for monitoring extracellular vesicle fusion and membrane interface pH dynamics.

CN121703068BActive Publication Date: 2026-06-02RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202610220527.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2026-02-24
Publication Date
2026-06-02
Estimated Expiration
2046-02-24

Smart Images

  • Figure CN121703068B_ABST
    Figure CN121703068B_ABST
Patent Text Reader

Abstract

This invention discloses a target-gated ratiometric pH sensor based on a dual CRISPR system of tetrahedral framework nucleic acids, belonging to the fields of biomedicine and nucleic acid nanotechnology. The sensor uses tetrahedral framework nucleic acids as a rigid scaffold, precisely assembling Cas12a, Cas13a, and their corresponding fluorescent reporter molecules in a 1:1 stoichiometric ratio. Their orthogonal pH responses form the basis of the ratiometric sensing. Target recognition-pH sensing logic gating is achieved through target-specific crRNA design. Cholesterol modification allows for stable anchoring on the lipid membrane surface. This invention also discloses the sensor's fabrication, membrane anchoring, pH monitoring, and target-gated function implementation methods. This sensor possesses advantages such as high-precision ratio measurement, accurate spatial arrangement, high specificity, stable membrane anchoring, and a wide pH response range, and can be used for precise monitoring of pH dynamics at biomembrane interfaces and during extracellular vesicle fusion.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • APE1 enzyme and miRNA dual-channel detection kit based on CRISPR-Cas13a system and application of APE1 enzyme and miRNA dual-channel detection kit

    CN118599840A

  • Nucleic acid mediator assisted ultrasensitive CRISPR biosensor

    CN120322563A